Baloxavir marboxil (BXM) represents a promising advance in antiviral chemotherapies for influenza infections. Identification of transmissible BXM-resistant strains in Japan may hit pause on widespread adoption of this therapy and could lead to revision of surveillance practices for emerging viruses.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Searching glycolate oxidase inhibitors based on QSAR, molecular docking, and molecular dynamic simulation approaches
Scientific Reports Open Access 19 November 2022
-
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses
Scientific Reports Open Access 22 April 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lee, N. & Hurt, A. C. Curr. Opin. Infect. Dis. 31, 520–526 (2018).
Shtyrya, Y. A., Mochalova, L. V. & Bovin, N. V. Acta Naturae 2, 26–32 (2009).
FDA approves new drug to treat influenza. U. S. Food and Drug Administration https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treat-influenza (2018).
Imai, M. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0609-0 (2019).
Omoto, S. et al. Sci. Rep. 8, 9633 (2018).
Noshi, T. et al. Antiviral Res. 160, 109–117 (2018).
Bloom, J. D., Gong, L. I. & Baltimore, D. Science 328, 1272–1275 (2010).
Moscona, A. New Engl. J. Med. 360, 953–956 (2009).
Frise, R. et al. Sci. Rep. 6, 29793 (2016).
Baym, M., Stone, L. K. & Kishony, R. Science 351, aad3292 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kormuth, K.A., Lakdawala, S.S. Emerging antiviral resistance. Nat Microbiol 5, 4–5 (2020). https://doi.org/10.1038/s41564-019-0639-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-019-0639-7
This article is cited by
-
Searching glycolate oxidase inhibitors based on QSAR, molecular docking, and molecular dynamic simulation approaches
Scientific Reports (2022)
-
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses
Scientific Reports (2021)